Atlas Trials

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Clinical trial NCT01361646 · COMPLETED

Trial details

NCT number
NCT01361646
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HyperuricemiaGout
Start date
2011-06-01
Primary completion
2013-01-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.